These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 21849968

  • 1. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
    Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW, Freedman BI.
    Kidney Int; 2011 Dec; 80(12):1339-43. PubMed ID: 21849968
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
    Freedman BI, Langefeld CD, Lu L, Divers J, Comeau ME, Kopp JB, Winkler CA, Nelson GW, Johnson RC, Palmer ND, Hicks PJ, Bostrom MA, Cooke JN, McDonough CW, Bowden DW.
    PLoS Genet; 2011 Jun; 7(6):e1002150. PubMed ID: 21698141
    [Abstract] [Full Text] [Related]

  • 3. Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
    Bonomo JA, Ng MC, Palmer ND, Keaton JM, Larsen CP, Hicks PJ, T2D-GENES Consortium, Langefeld CD, Freedman BI, Bowden DW.
    Clin J Am Soc Nephrol; 2014 Aug 07; 9(8):1434-40. PubMed ID: 24948143
    [Abstract] [Full Text] [Related]

  • 4. Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD.
    Freedman BI, Hicks PJ, Bostrom MA, Comeau ME, Divers J, Bleyer AJ, Kopp JB, Winkler CA, Nelson GW, Langefeld CD, Bowden DW.
    Nephrol Dial Transplant; 2009 Nov 07; 24(11):3366-71. PubMed ID: 19567477
    [Abstract] [Full Text] [Related]

  • 5. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA, Friedman DJ, Lu L, McWilliams DR, Chou JW, Sajuthi S, Divers J, Parekh RS, Li M, Genovese G, Pollack MR, Hicks PJ, Bowden DW, Ma L, Freedman BI, Langefeld CD.
    Am J Nephrol; 2015 Nov 07; 42(2):99-106. PubMed ID: 26343748
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
    Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, Birmingham DJ, Hebert LA, Hicks PJ, Segal MS, Edberg JC, Brown EE, Alarcón GS, Costenbader KH, Comeau ME, Criswell LA, Harley JB, James JA, Kamen DL, Lim SS, Merrill JT, Sivils KL, Niewold TB, Patel NM, Petri M, Ramsey-Goldman R, Reveille JD, Salmon JE, Tsao BP, Gibson KL, Byers JR, Vinnikova AK, Lea JP, Julian BA, Kimberly RP, Lupus Nephritis–End‐Stage Renal Disease Consortium.
    Arthritis Rheumatol; 2014 Feb 07; 66(2):390-6. PubMed ID: 24504811
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S, Rosset S, Shemer R, Yudkovsky G, Selig S, Tarekegn A, Bekele E, Bradman N, Wasser WG, Behar DM, Skorecki K.
    Hum Genet; 2010 Sep 07; 128(3):345-50. PubMed ID: 20635188
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
    Ma L, Langefeld CD, Comeau ME, Bonomo JA, Rocco MV, Burkart JM, Divers J, Palmer ND, Hicks PJ, Bowden DW, Lea JP, Krisher JO, Clay MJ, Freedman BI.
    Kidney Int; 2016 Aug 07; 90(2):389-395. PubMed ID: 27157696
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
    Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WH, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Freedman RG, Zhang W, Parekh RS, Choi MJ, Nelson GW, Winkler CA, Kopp JB, SK Investigators.
    Kidney Int; 2013 Jan 07; 83(1):114-20. PubMed ID: 22832513
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. MYH9 and APOL1 are both associated with sickle cell disease nephropathy.
    Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJ.
    Br J Haematol; 2011 Nov 07; 155(3):386-94. PubMed ID: 21910715
    [Abstract] [Full Text] [Related]

  • 17. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
    Freedman BI, Langefeld CD, Turner J, Núñez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J.
    Kidney Int; 2012 Oct 07; 82(7):805-11. PubMed ID: 22695330
    [Abstract] [Full Text] [Related]

  • 18. Target organ damage in African American hypertension: role of APOL1.
    Freedman BI, Murea M.
    Curr Hypertens Rep; 2012 Feb 07; 14(1):21-8. PubMed ID: 22068337
    [Abstract] [Full Text] [Related]

  • 19. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
    Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, Fornage M, Parekh RS, Coresh J, Kao WH.
    Clin J Am Soc Nephrol; 2015 May 07; 10(5):784-90. PubMed ID: 25887069
    [Abstract] [Full Text] [Related]

  • 20. Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.
    Palmer ND, Ng MC, Langefeld CD, Divers J, Lea JP, Okusa MD, Kimberly RP, Bowden DW, Freedman BI.
    J Am Soc Nephrol; 2015 May 07; 26(5):1021-5. PubMed ID: 25249559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.